P24. Aviscumine enhances NK- cytotoxicity against tumor cells
Main Authors: | Gamerith, G, Amann, A, Schenk, B, Auer, T, Huber, JM, Cima, K, Lentzen, H, Löffler-Ragg, J, Zwierzina, H, Hilbe, W |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072179/ |
Similar Items
-
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study
by: Trefzer, Uwe, et al.
Published: (2014) -
Development of an Innovative 3D Cell Culture System to Study Tumour - Stroma Interactions in Non-Small Cell Lung Cancer Cells
by: Amann, Arno, et al.
Published: (2014) -
Infiltration of immune cells into cancer cell/stroma cell 3D microtissues
by: Koeck, Stefan, et al.
Published: (2015) -
CD86 Is an Activation Receptor for NK Cell Cytotoxicity against Tumor Cells
by: Peng, Yanmeng, et al.
Published: (2013) -
Evaluation of assays for drug efficacy in a three-dimensional model of the lung
by: Huber, Julia M., et al.
Published: (2016)